chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up at around 12:22 am to chest pain radiating to my left shoulder blade and shortness of breath with a pain rating of 6/10 worsening when lying flat on my back or becoming active. I figured I slept wrong so tossed and turned and went back to bed. Later that day around 6 pm I got stung twice by a wasp on my right middle finger. Normally nothing happens but small dots appearing where I was stung but this time within 1 hour my whole right hand swelled up. I took 2 tabs of Benadryl and went home with my wife and went to bed. When I woke up around 1: 33 am my whole hand was still swollen but this time it moved all the way up to my elbow along with the chest pain radiating to my left shoulder blade. I told my wife and she told me to go to the ED in the morning when I woke back up if my hand was still swollen. I went and let them know this has never happened before and I've been stung many times in the past and not too recently. They gave me Proctosol and a prescription for it which I never filled. I never brought up the pain in my chest though because I thought maybe I slept wrong. Later in the day, my hand got better but my chest pain still remained so I tried stretching but noticed it didn't hurt when I moved my head like it normally does so got worried a little but didn't do anything about it. Later that night same thing and this time I had a very difficult time sleeping so decided to go to the ER in the am for my chest pain. While in the parking lot I ran into a nurse that works in the cardiologist dept. and explained what was going on, he said unless it feels like a heart attack they probably wouldn't do much, and unless I really think I needed to that just try and give it some more time to go away. That night it didn't hurt as bad so I never went back. It still happens off and on but not as bad but enough that I made an appointment for Sept. 4th with my family doctor to see what he thinks about it. I brought it up to my cousin who is a nurse recently and she told my young adult like myself have been developing myocarditis or pericarditis from the mRNA vaccines so I hope it's not that but find it very weird how the pain came along and the reaction I had to the wasp sting when that has never happened like that in my life before.
Diarrhea beginning on 1/16/21, ongoing; chills beginning in 1/15/21, ongoing; soreness beginning 1/14/21 ending 1/19/21; swelling and itching at injection site beginning 1/18/21 ending 1/21/21;  swelling, soreness and warmth on collarbone area and swelling and pain in supraclavicular lymphnode on left side beginning 1/16/21, ongoing; swollen lymphnode found in neck 1/20/21
Dose 1 October 1st 2021, 2nd dose Aug 12th 2022/ TWINRIX LATE 2ND DOSE; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 20-year-old male patient who received HAB (Twinrix) (batch number 4F3YY, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (on 1st October 2021, the patient received 1st dose of Twinrix, expiry date: 8th February 2022 and batch number: DK23D).   On 12th August 2022, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 12th August 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 16-AUG-2022 Reporter's Comment: The reporter reported that the patient received late 2nd dose of Twinrix.  The reporter consented to follow up. Additional Supportive Information: The patient received the 2nd dose of Twinrix later than the recommended schedule, which led to lengthening of vaccination schedule.
tired, cranky, poor appetite; wed AM big welts-raised on torso c/o itchy Thursday took DPH; cleared hives w/in hrs;
patient received vaccine past its 30 days expiry date/ vaccine went in to 2-8C thaw state; patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ vaccine went in to 2-8C thaw state) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022 at 3:28 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Feb-2022 at 3:28 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ vaccine went in to 2-8C thaw state). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ vaccine went in to 2-8C thaw state) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The patient's ethnicity was reported as private of any race.  It was reported that, the vaccines went in to 2-8 C thaw state on or about 24-Dec-2021.  No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
2 weeks after the shot I developed rash on my left arm. The rash is in the form of a circle and size of a palm. Red and itchy.
The Moderna Bivalent Vaccine had expired on 5-19-2023. Inmate had signs and symptoms. And no adverse outcomes to date.
arm soreness; This case was reported by a consumer and described the occurrence of pain in arm in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was vaccinated with 1st dose of Shingrix and experienced arm soreness For tolerance with 2nd dose refer case US2020242307. The reporter did not consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020242307:same reporter
has not had second shot, past 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided by the reporter.  No treatment information was provided.
The Chief Complaint is: 17 y/o F with history of PCN allergy (reports "anaphylactic shock" as a child) presents for first COVID vaccine.  Discussed risk of remote PCN allergy and merits additional observation here after vaccination.  Patient agreed to vaccination.  During observation period the patient became tearful and stated she was feeling dizzy.  This was about 15 minutes after the injection.  She was taken to the treatment area for assessment.  Endorsed dizziness, headache, twitching, anxiety.  Denied dyspnea, itching, globus, chest pain (or pain of any type), abd pain or swelling.  17 y/o F with dizziness, anxiety but does not appear to be having a vasovagal or anaphylactic reaction.  Recommend further observation - called EMS for evaluation and transport to medical facility  No treatment given as BP normal, no rash or symptoms of anaphylaxis.  Will file VAERS follow up but most likely cause for symptoms currently is anxiety.
Dose number=3; noticed no symptoms 5 days from potential exposure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "wears contact lenses" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, unknown manufacturer, dose 1), for covid-19 immunization; Covid-19 vaccine (Primary immunization series completed, unknown manufacturer, dose 2), for covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Dose number=3"; EXPOSURE TO SARS-COV-2 (non-serious), outcome "unknown", described as "noticed no symptoms 5 days from potential exposure". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient receive any other vaccines within 4 weeks prior to the COVID vaccine: Unknown. Other medications the patient received within 2 weeks of vaccination: unknown.  The lot number for COVID-19 Vaccine - Manufacturer Unknown was not provided and will be requested during follow up.
8 days after getting the Pfizer COVID-19 vaccine i got a tingling headache on the right side of my head near my temple and the next day it spread to my whole right side of my head, creating a painful bed-ridden migraine. The next morning after that, the 3rd of April it turned into a rash that eventually turned into blisters and went down to the tip of my nose, down my forehead and near my eye, to which it swelled. I went to the doctor to get help and was diagnosed with shingles a day afterwards. I have gotten medication and am still on it to this day (currently 4/9/2021)
Information has been received from a Registered Nurse, via a company representative, referring to a 70 year old female patient. The patient did not have medical history, concurrent conditions or concomitant therapies. On an unspecified date in September 2017 (also reported as "in the last 2 weeks"), the patient was vaccinated with a dose of PNEUMOVAX 23 lot # N011305, expiration date of 20-JAN-2019, intramuscularly (dose, anatomical location and expiration date were not reported) for prophylaxis. On an unknown date in September 2017 (reported as "within a day of receiving the vaccine"), the patient developed cellulitis. The reporting registered nurse stated that on an unspecified date, the patient was examined and treated with unspecified antibiotics at the facility.  The outcome of the cellulitis was reported as recovering and the causality between the vaccination with and the event was not reported. Upon internal review, the cellulitis was considered as a medically significant event. This is one of several reports received from the same source. Sender's Comments: US-009507513-1710USA001898: US-009507513-1709USA014175.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not provided. In August 2015, the patients were vaccinated with RECOMBIVAX HB lot # J013394, expiration date 25-AUG-2016 and lot number L001456, expiration date 22-OCT-2016 (routes were not provided). Concomitant therapy information was not provided. In August 2015, there was an incorrect product storage as unspecified doses of improperly stored RECOMBIVAX HB were administered to unspecified patients. No adverse events were reported. It was unknown if the patients sought medical attention. At the time of the report, the patients' status was unknown. Additional information has been requested.
1st dose in 2019, hadn't received the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose in 2019, hadn't received the 2nd dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 10-Mar-2023 The reporter did not consent to follow-up. Till the time of reporting  the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
"croup-like" symptoms immediately after receiving hep A #2 and MMR #1
Vomiting, persistent diarrhea started 4-30-08 at midnight. temp 101.4 degrees, Listless; High pitched crying. Pedialyte given. To ER on May 2. Vomiting, diarrhea ended May 3 at noon.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date in March 2016, the patient was vaccinated with a dose of  GARDASIL 9 first dose (dose, route and site of administration, lot # and expiry date were not reported). On unknown dates in July 2016 and August 2016, the patient was vaccinated with the second and third dose of GARDASIL 9, respectively. No product quality complaint was involved. Additional information has been requested.
69 y/o with past medical history of HTN, Heart attack, Asthma, Gastritis, Spinal Surgery x2 and Bells Palsy who presents with nervousness prior to vaccination and then worsening anxiety, nausea and dizziness immediately post vaccination. Patient states that this is the first dose in the two-dose series. Patient states that she received the vaccination to the left arm. Patient denies headache, sore throat, difficulty breathing, shortness of breath or chest pain. Patient evaluated by NP and Paramedics. Patient started complaining of difficulty breathing, so patient was placed on 2L O2 by nasal cannula. Patient initial vitals with hypertension present (176/99 BP, 65 HR, 99% RA). Patient states that blood pressure medication was taken this am. Patient states nervousness and fear of needles maybe the cause of symptoms. Patient monitored for 20 mins with resolution of symptoms. Patient was weaned off O2 with no further complaints of difficulty breathing. Patient denies nausea and dizziness. Patient BP upon discharge within normal limits, 142/78. Patient discharged in stable condition.
LOCAL RASH, REDNESS AND BLISTERING. NO TREATMENT OTHER THEN KEEP CLEAN, REPORT WORSENING OF SYMPTOMS
did test positive for COVID at the outside ED.  She denies fever, chills, sore throat, cough, shortness of breath, diarrhea.  Dose number 3 Admin Location (Facility): Clinics 10/12/2021 lot: 024C21A
Weakness Joint pain Nausea IBS flare up- abdominal pain and increased bowel motility Dizziness
area of 3x6 cm erythema and induration at site present tow days after injection.  Afebril to apply local compress and take NSAIDs.
Immediately p/immun, pt held breath started crying; Mom started to leave pt vomited; On way home started turning blue; To MD office cyanotic w/pallor around mouth; Hospitalized for observation x 48hrs;
This spontaneous report was received from a medical assistant referring an unknown number of unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. It was reported that, since 12-SEP-2017, the patients were vaccinated with improperly stored dose of VARIVAX lot # N014369 with expiration date of 09-MAY-2019 and lot # N014630 with expiration date of 11-MAY-2019, for prophylaxis (strength, dose, route and frequency were not reported). No adverse effects reported. It was stated that the vaccines underwent a temperature excursion of 15°F (degrees Fahrenheit) to 46°F (32F) for 1 hour; no previous temperature excursion was done. The call was because of a "data logger".
2/18/21: Chills, body aches, and fatigue. Lasted all day.  2/19/21: little body aches, headache. Lasted all day.  2/20/21: At 1am, started feeling chills, body aches, and fatigue. Currently experiencing at the time of this posting (2:05am).
Headache- 10:00 am Nausea- 11:30 am Diarrhea- 1:30 pm Sore Right Arm- Since the day I did it ( yesterday)
PATIENT RECEIVED VACCINE ON 9-15. ON FRIDAY 9-25 RASH BEGAN AT INJECTION SITE ON LEG AND CONTINUED TO DOUBLE IN SIZE UNTIL COVERING THE WHOLE BODY (EXCEPT SCALP) BY SUNDAY. PATIENT REVISITED DOCTOR OFFICE AND WAS TOLD BY PRACTITIONER THAT IT WAS A MEASLES RASH, PRESCRIBED HYDROCORTISONE CREAM. WAS NOT EFFECTIVE, SAW DERMATOLOGIST ON 10-23, PRESCRIBED TRIAMCINOLONE WHICH IS REPORTED BY MOTHER TO BE WORKING (NOT QUICKLY, BUT NOTICEABLY).
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. Concurrent condition and medical history were unknown. On unknown dates in June 2015 the patients were vaccinated with improperly stored GARDASIL (lot # K006960, expiration date 19-FEB-2017, dose and route were unknown). This is one of several reports received from the same reporter. Additional information has been requested.
2 min after getting the vaccine I started to feel dizzy, my heart rate was high, nausea , vomiting and my throat felt hot /cold.... it was something that I never experienced before.
rash/hives all over body.  Intense itching, redness, skin is raised and very hot to touch
Patient took 1 dose of expired Vivotif; On 22JUN2021 a non-serious spontaneous report was received from a pharmacist:  A pharmacist reported that a 66 year old male had taken one dose of Vivotif (typhoid vaccine live oral Ty21A) that was expired (PT: Expired product administered). The patient did not report any adverse events after consuming the expired Vivotif (lot unknown).   No medical history, concomitant medications, or further information is available.; Sender's Comments: A spontaneous case of administration of expired capsule of Vivotif (unknown lot number and expiration date), in a 66-year-old male consumer with no associated AEs. No further information is expected as there is no consent for follow-up. Per medical assessment with limited information, this case is non-serious.
Received rotavirus #3, PREVNAR 13, IPV #3, Dtap #3, Hib #3 on 5/17/13 at clinic. Hives started morning of 5/23/13.
PATIENT PRESENTED ON 2/2/18 WITH A RED RASH THAT ENCIRCLED HER ARM ABOVE HER ELBOW. THIS WAS SEVERAL INCHES AWAY FROM THE TWO INJECTION SITES IN HER LEFT DELTOID. I ADVISED HER TO BE SEEN BY HER PCP BECAUSE I WAS NOT SURE THAT THE RASH WAS RELATED TO THE VACCINES. THE PATIENT WAS NOT EXPERIENCING ANY PAIN OR DISCOMFORT.
Pt rec'd vaccination to LUE on 4.9.21. Pt denies any trauma to LUE. Pt reports L wrist/hand pain, swelling, numbing, burning, tingling that started 4.13.2021 (Friday at around 1700 hrs). In our ED now, awaiting to be seen by our Hospitalist for possible admission to the hospital.
Patient is an 85-year-old male with past medical history of ischemic cardiomyopathy and heart failure with recovered EF, sick sinus syndrome status post pacemaker, dementia, hypertension, HLD who was admitted for septic shock presumed secondary to pneumonia and UTI.  Intubated shortly after arrival to the ED.  Patient was also profoundly hypotensive and started on vasopressor support that was quickly escalated to 3 medications.  COVID-positive.  Chest imaging showed bilateral airspace disease.  Started on broad-spectrum vancomycin and meropenem.  During admission, the patient was observed to have multiple intermittent ventricular tachyarrhythmias, causing his implanted defibrillator to release shocks multiple times.  He was started on amiodarone drip with improvement in heart rate and cardiology was consulted.  Lab work remarkable for AKI likely secondary to shock and hypokalemia.  The patient also appeared moderately malnourished with muscle wasting on exam.  Patient was noted to have no response to verbal or tactile stimuli when sedation was paused.  Patient's family arrived to hospital and is critical condition was discussed with them.  His 2 daughters are the decision-makers for the patient and they both agreed that his current condition is not conducive to his wishes.  They requested that the patient be liberated from the ventilator and any aggressive measures be discontinued including pressor support.  Patient was liberated from the ventilator, all drips were stopped.  Shortly after this occurred, the patient was noted to bradycardia to asystole.  ICU team was called to the bedside to pronounce the patient.  Time of death pronounced at 1119.   Condition at Discharge: Expired   Disposition:  Morgue
Client came in for travel shot for job assignment at 5:00. Client received the following vaccine Hep A, Hep B, Tdap and Typhoid. Client began passing out at 5:30 called for assistance and was given ammonia inhaler. He began coming around the later started passing out again ammonia inhaler was given again. Client came through and was taken to exam room to be monitored vital signs 5:10 115/69 73, 5:20 115/74 75, and 5:30 112/76 72. Client was stable and began taking fluids and crackers. He the reported he had not eaten anything since noon. He also informed staff that he had passed out at the doctor office after arm injection but did not tell anyone. Client was feeling better and stable was dismissed at 5:45.
The patient called at 6:00 PM stating that she was shivering really badly.  She was also having trouble speaking due to the shivering.
24 hours after the vaccination the pt developed tachycardia and chest pain in the left pericardium some shortness of breath. She developed fatigue and low grade temperature (not documented to my knowledge). Symptom of chest pain persisted intermittently for a few days along with intermittent tachycardia
1/14/21 Developed aching to my left underarm/armpit area while at rest.  Aching has been ongoing and intermittent.  1/17/21 Developed left ear "fullness".  On 1/20/21 went to GYN for exam, explained left underarm pain, told that my breast exam appeared normal, but she questioned if my left ear fullness and left under arm pain were related.  1/21/21 Left Ear "fullness" began to radiated causing left temporal pressure, spreading across forehead.  Pressure developed behind both eyes.  Sudden onset of dizziness occurred.  Went to urgent care where they said I had swollen lymph nodes and believed I was having a auto immune response to something.  Told I received the vaccine on 1/7/21, they said the symptoms could be related to the vaccine.  1/22/21 Notice I would occasionally feel like I had a "lump or pressure" to the side of my throat.   As of present I am continuing to have Left  Ear "fullness", left underarm aching, and bilateral eye pressure has bee intermittent yet ongoing.
I got the vaccine at 10:30 am  2:00 pm - diarrhea?s  4:00pm- vomiting   Friday - Day was ok  Saturday 1 - 1:00pm - 4:00pm Fever and body aches  I take 2 caplets of Topcare  health Extra Strength Acetaminophen 500mg   Sunday - stomach and back pain. Headache and dizziness